In the dStromal-late mesenchymal cell subtype, FXYD5 was specifically localized to stromal cells of endometriotic lesions and showed markedly higher expression (p = 0.02) in endometriosis tissues compared to control tissues, again confirming our previous analytical results (Figure 7D). Here, FXYD5 is linked to endometriosis.